Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

ed to the fair value of these rights. Excluding

these rights, the fair values of the assets and liabilities of the

joint venture as of March 31, 2008 were not significant.

(2) As of March 31, 2008, Other assets includes $80,100K for the fair

value of the five million shares of Isis Pharmaceuticals, Inc. common

stock that we purchased in February 2008.

GENZYME CORPORATION

RECONCILIATION OF GAAP TO NON-GAAP EARNINGS

For the Three Months Ended March 31, 2008

(Amounts in thousands, except per share data)

Dilution

Due to Premium on

Common Stock Strategic Equity

NON-GAAP Equivalents Investment

Income Statement

Classification:

Total revenues $1,100,061

Cost of products

and services sold $(265,799)

Selling, general and

administrative $(295,497)

Research and development $(180,312) $(69,900)

Amortization of

intangibles $-

Equity in income (loss)

of equity method

investments $188

Minority interest $463

Gains (losses) on

investments in equity

securities $775

Other $(160)

Investment income $14,870

Interest expense $(1,655)

Summary:

Income (loss) before

income taxes $372,934 $- $(69,900)

(Provision for) benefit

from income taxes $(112,039) $- $13,428

Net income (loss) $260,895
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 Texas ... John Sharp, Texas A&M Health Science Center CEO ... Department of Health and Human Services (HHS), State ... a national pandemic influenza vaccine manufacturing facility in ... an anchor for the Texas A&M Biocorridor – ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 On Tuesday, ... and Sen. Jim Risch for National Lab Day on ... from across the national laboratory system. Durbin and Risch ... aims to increase awareness of the reach of the ... and discoveries to address some of our nation's most ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... 2014 Research and Markets ... N-acetylcysteine Industry Report 2014" report to their ... Report 2014 is a professional and in-depth study ... industry. The report provides a basic ... and industry chain structure. The N-acetylcysteine market analysis ...
Breaking Biology Technology:Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global N-acetylcysteine Industry Report 2014 2
... Inc. , a biotechnology company focused on the development ... diseases, has entered into an in-vitro diagnostics patent license ... firm. , ,Under the agreement, which will be effective ... enzymes in its products. Prodesse also receives the authority ...
... Allis, Wis. - After conducting a lengthy financial ... Healthcare has announced the resignations of three executives, ... errors in its financial statements. , ,The stock market ... as the value of Merge shares declined by 41 ...
... - The relocation of one area biotech has resulted in ... take it even higher. , ,And while GWC Technologies ... interactions on bioarrays, is not yet in the penthouse, the ... high-tech product development, according to president and CEO Tim Burland. ...
Cached Biology Technology:Merge execs step down following investigation 2Merge execs step down following investigation 3Madison biotech continues its climb 2Madison biotech continues its climb 3Madison biotech continues its climb 4
(Date:9/18/2014)... The ability to acquire and creatively manipulate spoken language ... over the past 6 million years of human evolution ... is the best candidate gene we now have," says ... LMU. In his efforts to understand the molecular biological ... step forward. The results of his latest study, undertaken ...
(Date:9/18/2014)... stored in DNA, tiny strands of nucleic acid that ... express this genetic data, our DNA is copied into ... that perform tasks in our cells. , Several ... molecule. Unlike all other known RNAs, this molecule is ... are abundant, little has been known about how they ...
(Date:9/18/2014)... colleagues have built the first smartphone app that ... behavioral trends. In other words, your smartphone knows ... don,t -- and how that affects you. , ... depression and loneliness to their academic performance, also ... for example, to monitor mental health, trigger intervention ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4
... Forest Service scientists have found that prescribed fires with the ... oak ecosystems. Forest Service researchers are helping land ... oak regeneration from acorns is a concern. "Acorns ... the most part protected from fire," says Cathryn Greenberg, Forest ...
... in JoVE , the Journal of Visualized ... spider silk from bacteria. The procedure presented in the ... standardizing a key step known as "post-spin." In this ... to increase fiber strength. These mechanical improvements produce uniform ...
... Waterlogged protein . . . Proteins, biological ... our bodies, are known to rely heavily on the ... remained unclear. In a paper published in Physical Review ... new evidence that suggests water is even more involved ...
Cached Biology News:Leaf litter and soil protect acorns from prescribed fire 2The future of biomaterial manufacturing: Spider silk production from bacteria 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2012 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2012 3
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
... to ADAMTS16 ( Abpromise for ... Antigen: Synthetic peptide based on ... Note: the amino acid sequence is ... 170690 SWISS ...
... Immunogen: KLH-conjugated, synthetic ... in which [ Ac K] corresponds to ... Accession Number: NM_003493 ... ~17kDa Quality Assurance: ...
synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: